The current state of stem cell therapy for peripheral artery disease

Nitin K. Gupta, Ehrin J. Armstrong, Sahil A. Parikh

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Patients with advanced peripheral arterial disease may develop critical limb ischemia with rest pain, non-healing ulcerations, and eventually may require major amputation despite currently available revascularization technologies. Stem cell therapies hold promise as novel therapeutics to promote vasculogenesis and improve tissue perfusion in these patients. This article reviews the current state of stem cell therapy for patients with peripheral arterial disease, with a focus on the cell types that have been studied, barriers to clinical development, and development of new endpoints for clinical trials.

Original languageEnglish (US)
JournalCurrent Cardiology Reports
Volume16
Issue number2
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Peripheral Arterial Disease
Cell- and Tissue-Based Therapy
Stem Cells
Amputation
Ischemia
Extremities
Perfusion
Clinical Trials
Technology
Pain
Therapeutics

Keywords

  • Critical limb ischemia
  • Peripheral artery disease
  • Stem cells

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The current state of stem cell therapy for peripheral artery disease. / Gupta, Nitin K.; Armstrong, Ehrin J.; Parikh, Sahil A.

In: Current Cardiology Reports, Vol. 16, No. 2, 2014.

Research output: Contribution to journalArticle

Gupta, Nitin K. ; Armstrong, Ehrin J. ; Parikh, Sahil A. / The current state of stem cell therapy for peripheral artery disease. In: Current Cardiology Reports. 2014 ; Vol. 16, No. 2.
@article{51d248adec054ac99397f0eef4b74b29,
title = "The current state of stem cell therapy for peripheral artery disease",
abstract = "Patients with advanced peripheral arterial disease may develop critical limb ischemia with rest pain, non-healing ulcerations, and eventually may require major amputation despite currently available revascularization technologies. Stem cell therapies hold promise as novel therapeutics to promote vasculogenesis and improve tissue perfusion in these patients. This article reviews the current state of stem cell therapy for patients with peripheral arterial disease, with a focus on the cell types that have been studied, barriers to clinical development, and development of new endpoints for clinical trials.",
keywords = "Critical limb ischemia, Peripheral artery disease, Stem cells",
author = "Gupta, {Nitin K.} and Armstrong, {Ehrin J.} and Parikh, {Sahil A.}",
year = "2014",
doi = "10.1007/s11886-013-0447-2",
language = "English (US)",
volume = "16",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "2",

}

TY - JOUR

T1 - The current state of stem cell therapy for peripheral artery disease

AU - Gupta, Nitin K.

AU - Armstrong, Ehrin J.

AU - Parikh, Sahil A.

PY - 2014

Y1 - 2014

N2 - Patients with advanced peripheral arterial disease may develop critical limb ischemia with rest pain, non-healing ulcerations, and eventually may require major amputation despite currently available revascularization technologies. Stem cell therapies hold promise as novel therapeutics to promote vasculogenesis and improve tissue perfusion in these patients. This article reviews the current state of stem cell therapy for patients with peripheral arterial disease, with a focus on the cell types that have been studied, barriers to clinical development, and development of new endpoints for clinical trials.

AB - Patients with advanced peripheral arterial disease may develop critical limb ischemia with rest pain, non-healing ulcerations, and eventually may require major amputation despite currently available revascularization technologies. Stem cell therapies hold promise as novel therapeutics to promote vasculogenesis and improve tissue perfusion in these patients. This article reviews the current state of stem cell therapy for patients with peripheral arterial disease, with a focus on the cell types that have been studied, barriers to clinical development, and development of new endpoints for clinical trials.

KW - Critical limb ischemia

KW - Peripheral artery disease

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=84896080578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896080578&partnerID=8YFLogxK

U2 - 10.1007/s11886-013-0447-2

DO - 10.1007/s11886-013-0447-2

M3 - Article

VL - 16

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 2

ER -